Aprea Therapeutics Inc — Balance Sheet (NASDAQ:APRE) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 92.81 M56.82 M30.16 M22.65 M23.98 M Total liabilities 15.41 M7.32 M3.2 M4.49 M3.46 M Total equity 77.4 M49.51 M25.64 M16.95 M19.31 M Total liabilities & shareholders' equities 92.81 M56.82 M30.16 M22.65 M23.98 M Total debt ————— Net debt —————

뉴스

Aprea Therapeutics Advanced Cancer Trial Shows Promising Results, Stock Soars - Aprea Therapeutics (NASDAQ:APRE)

Aprea reports second partial response in endometrial cancer trial

Aprea Therapeutics appoints Eugene Kennedy as chief medical advisor

Aprea Therapeutics (APRE) CEO buys $25,000 in shares

Aprea Therapeutics stock falls after early-stage cancer drug data

Aprea Therapeutics raises $5.6 million in private placement

Aprea reports first partial response in Phase 1 cancer drug trial

New Strong Sell Stocks for January 19th

New Strong Sell Stocks for Jan. 14

Aprea Therapeutics reports progress in cancer drug development

Aprea Therapeutics raises $3.1 million in private placement

Aprea’s WEE1 inhibitor shows disease stabilization in early trial